BLENDE DRUG INC
NPI 1275336174
Clinic/Center - Primary Care in Pueblo, CO
About Blende Drug Inc NPPES
Official registry information on file with the National Plan and Provider Enumeration System.
BLENDE DRUG INC (NPI 1275336174), doing business as Blende Drug, is a healthcare organization registered as a primary care in Pueblo, Colorado and active in the NPI registry since March 2025. The organization holds a CLIA Waiver certificate valid through December 7, 2027 and lists John Joseph Cernac, Pic/president, as its authorized official.
NPPES Registry Identity
Specialties & Licenses 2
Other Names 1
Other Identifiers 1
CLIA Laboratory Certificates CMS CLIA
Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.
Certificate of Waiver 06D2141173
Blende Drug, Inc · Pueblo, COOther Providers at the Same Location NPPES 4
Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.
Frequently Asked Questions NPPES & CMS
Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.
What is Blende Drug Inc's NPI number?
The NPI number for Blende Drug Inc is 1275336174. It was assigned to this organization in the NPPES registry on March 28, 2025. The provider was formerly known as Blende Drug.
Where is Blende Drug Inc located?
Blende Drug Inc is located at 1910 Santa Fe Dr, Pueblo, CO 81006. The listed phone number is (719) 542-2477.
What is Blende Drug Inc's specialty?
The primary specialty registered for this NPI is Clinic/Center, specializing in Primary Care, with taxonomy code 261QP2300X.
Does Blende Drug Inc hold a CLIA laboratory certificate?
Yes. A Certificate of Waiver (number 06D2141173) is associated with this NPI, valid through December 7, 2027. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.
When was this NPI record last updated?
The NPPES record for Blende Drug Inc was last updated on March 28, 2025. NPI Profile syncs with the weekly NPPES data releases published by CMS.
